null
null
OncologyStat
®
One Source, Many Resources.
®
By Elsevier
GYN (OVARY) CANCER
Refine Results:
All Categories
Epidemiology and Etiology (153)
Prevention and Screening (77)
Diagnosis and Staging (141)
Treatment (286)
Supportive Oncology (25)
News
Study Fine-Tunes Link Between Endometriosis, Ovarian Cancer
Elsevier Global Medical News, 2012 Apr 12, AR Schonfeld
FDA Acts to Curb Doxorubicin, Methotrexate Shortages
Elsevier Global Medical News, 2012 Feb 21, A Ault
BRCA1 and BRCA2 Mutations Tied to Better Ovarian Cancer Survival
Elsevier Global Medical News, 2012 Jan 24, S Worcester
Bevacizumab Effective With First-Line Treatment for Ovarian Cancer
Elsevier Global Medical News, 2012 Jan 4, MA Moon
EXPERT COMMENTARY
Aflibercept Prevents Ascites Recurrence in Advanced Ovarian Cancer
Elsevier Global Medical News, 2011 Dec 21, MA Moon
More News ›
Journal Scans: Research
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
J Clin Oncol, 2012 Apr 23, C Aghajanian, et al
EXPERT COMMENTARY
Cancer Incidence in Patients With Polyglutamine Diseases
Lancet Oncol, 2012 Apr 12, J Ji, et al
Mutation Analysis of RAD51D in Non-BRCA1/2 Ovarian and Breast Cancer Families
Br J Cancer, 2012 Apr 10, DJ Osher, et al
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
N Engl J Med, 2012 Mar 27, J Ledermann, et al
The Chemokine, CXCL12, Is an Independent Predictor of Poor Survival in Ovarian Cancer
Br J Cancer, 2012 Mar 27, A Popple, et al
More Journal Scans: Research ›
Journal Scans: Review
Carcinosarcoma of the Ovary: A Review of the Literature
Gynecol Oncol, 2012 Apr 1, MG Del Carmen, et al
Gynaecological Cancers in Pregnancy
Lancet, 2012 Feb 11, P Morice, et al
New Biologic Agents for the Treatment of Gynecologic Cancers
Hematol Oncol Clin North Am, 2012 Feb 1, N Horowitz, et al
Reporting of Myelotoxicity Associated With Emerging Regimens for the Treatment of Selected Solid Tumors
Crit Rev Oncol Hematol, 2012 Feb 1, A Chan, et al
Evolution of Platinum Resistance in High-Grade Serous Ovarian Cancer
Lancet Oncol, 2011 Nov 1, SL Cooke, et al
More Journal Scans: Review ›
Expert Opinion
Early Detection of Ovarian Cancer in Symptomatic Women
Lancet Oncol, 2012 Mar 1, JR van Nagell
Link Between Endometriosis and Ovarian-Cancer Subtypes
Lancet Oncol, 2012 Feb 22, C Gourley
VEGF Inhibitors and Advanced Ovarian Cancer
Lancet Oncol, 2011 Oct 11, G Jayson
Ten Practice Changes I Will Make After Attending ASCO 2011
2011 Jun 28, Jeffrey Kirshner, et al
Ovarian Cancer—New Thinking on Old Regimens
2011 Feb 23, Nelson Teng
More Expert Opinion ›
Chemotherapy Regimens
Topotecan (oral) (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel I.V., cisplatin I.V. or I.P., paclitaxel I.P. (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel, cisplatin (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel, carboplatin (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›
Videos
Personalized Medicine: A Long Way to Go
EJC News Focus, 2011 Nov 1
Expert Gives Overview of Gamechangers at 2011 ASCO Annual Meeting
Elsevier Global Medical News, 2011 Jun 4
Drug for Ovarian Cancer?
Elsevier Global Medical News, 2011 Jun 4
Collaboration Aims to Raise Women's Cancer Awareness
ASCO, 2008 May 30, Mary Ellen Schneider
Summary of Key Points
Ovaries and Fallopian Tubes
Abeloff's Clinical Oncology, 4th ed. 2008
Comment
Print page
Share page
RSS feeds
Updated Key Points: GYN (Ovary) Cancer
Summary information about GYN (ovary) cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›
When the Smoke Clears
Experts discuss the true clinical implications of watershed developments in oncology research.
Read more ›
Commentary
Ten Practice Changes I Will Make After Attending ASCO 2011
Read more ›
Categories
News
Journal Scans
Expert Opinion
Drugs and Regimens
Conferences
CME
Videos
Supportive Care
Skeletal-Related Events
Complications, GI and Oral
Hematologic Support
Infectious Complications
Neurologic Complications
Pain
Vascular Complications
Cancer Type
Bladder
Bone
Breast
Breast (ER-Positive)
CNS/Brain
Colon and Rectum
Endocrine System
Esophagus
GYN (Non-Ovary)
GYN (Ovary)
Head and Neck
Hodgkin's Lymphoma
Kidney (Renal Cell)
Leukemia
Liver and Bile Duct
Lung
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Diseases
Non-Hodgkin's Lymphoma
Pancreas
Pediatric Cancers
Prostate
Rare Cancers
Skin
Soft-Tissue Sarcoma
Stomach
Testicle
GYNOvary/
anonymous
none
none
none
n
Advanced Search
Email Address
Password
Remember Me
Forgot your password?
Not a member?
Free registration
Elsevier
Home
Site Map
Cancer Types
About OncologySTAT
Privacy Policy
Terms of Use
Contact Us
Advertise
Copyright © 2012
Elsevier Inc.
All rights reserved.